Oncostatin-M as a novel biomarker in colon cancer patients and its association with clinicopathologic variables.

---

Copy For Citation

Gurluler E., Tumay L. V., Guner O. S., Kucukmetin N. T., Hizli B., Zorluoglu A.

European review for medical and pharmacological sciences, vol.18, no.14, pp.2042-7, 2014 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 18 Issue: 14
• Publication Date: 2014
• Journal Name: European review for medical and pharmacological sciences
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.2042-7
• Keywords: Oncostatin M, Colon cancer, Clinicopathologic variables, COLORECTAL-CANCER, GROWTH-INHIBITION, CELLS, INTERLEUKIN-6, CYTOKINES, MITOGEN, MARKERS, IDENTIFICATION, OSTEOSARCOMA, EXPRESSION
• Acibadem Mehmet Ali Aydinlar University Affiliated: Yes

Abstract

OBJECTIVE: The aim of this study was to evaluate preoperative serum oncostatin M (OSM) concentration as a diagnostic marker in colon cancer patients and its association with clinicopathologic variables.